- Show all
- Abigail Coursolle
- Brian Brooks
- Fabiola Carrión
- Amy Chen
- daryln
- Corey Davis
- Andrew DiAntonio
- Elizabeth Edwards
- Candace Gibson
- Sarah Grusin
- Héctor Hernández-Delgado
- Rachel Holtzman
- Priscilla Huang
- Alicia Kauk
- Jennifer Lav
- Leonardo Cuello
- Jeremy Leaming
- Kimberly Lewis
- lhigashi
- lmilani
- David Machledt
- Elizabeth McCaman
- Catherine McKee
- Joe McLean
- Michelle Lilienfeld
- National Health Law Program Team
- Hayley Penan
- Jane Perkins
- Alexis Robles
- Susan Berke Fogel
- Sarah Somers
- Elizabeth G. Taylor
- veng
- Wayne Turner
- Mara Youdelman
- Show all
- Alaska
- Arizona
- Arkansas
- California
- Colorado
- Connecticut
- District of Columbia
- Florida
- Georgia
- Hawaii
- Idaho
- Illinois
- Indiana
- Iowa
- Kansas
- Kentucky
- Maine
- Maryland
- Massachusetts
- Michigan
- Mississippi
- Missouri
- Montana
- National
- New Hampshire
- New Mexico
- New York
- North Carolina
- Oklahoma
- Oregon
- Pennsylvania
- Tennessee
- Texas
- Utah
- Virginia
- Washington
- Show all
- Abortion
- Child and Adolescent Health
- CHIP
- Civil Procedure
- Civil Rights
- Cost-sharing
- Data Collection
- Defending Medicaid
- Demonstrations
- Disability Rights
- Dual Eligible Beneficiaries
- Eligibility and Enrollment
- EPSDT
- Exchanges/Marketplaces
- Family Planning
- HCBS/LTSS
- Health Care Reform
- Health Care Refusals
- Health Disparities
- Health Reform
- HIV/AIDS and Sexual Health
- Language Access
- LGBTQ Health
- Litigation
- Managed Care
- Medicaid
- Mental Health
- Nondiscrimination
- Oral Health
- Pregnancy
- Prescription Drugs Marketplace
- Prescription Drugs Medicaid
- Privacy and Confidentiality
- Public Health
- Reproductive Health
- Services
- Supreme Court
- Waivers and Demonstrations
- Women's Health
Archives
- July 31, 2018
National Health Law Program in Comments to HHS Opposes Changes to Title X
Read moreIn comments to the U.S. Department of Health and Human Services (HHS), the National Health law Program strongly opposes the proposed changes to the Title X program. NHeLP argues that by reconfiguring who receives Title X funding, as well as the scope of family planning methods and services that…
- July 27, 2018
Civil, Human Rights Groups’ Amicus Brief in 2020 Census Case, San Jose v. U.S.
Read moreA broad array of civil and human rights groups filed an amicus brief in San Jose and Black Alliance For Just Immigration v. Ross, in support of the litigation challenging the U.S. Department of Commerce's decision to add a "citizenship" question to the 2020 census. The brief led by the…
- July 27, 2018
Civil and Human Rights Groups’ Amicus Brief in 2020 Census Case (CA v. U.S. )
Read moreAn array of advocacy groups filed an amicus brief in California v. Ross, siding with Calif. Attorney General Xavier Becrra's lawsuit challenging the U.S. Department of Commerce's decision to add a "citizenship" question to the 2020 census. The brief led by the Leadership Conference on Civil and Human Rights,…
- July 26, 2018
Federal Court Blocks Wisconsin Regulation Banning Coverage of Health Care Services for Transgender Medicaid Beneficiaries
Read moreCourt Found State Medicaid Policy Likely Violates Federal and Constitutional Rights of Wisconsin's Transgender ResidentsWashington – A U.S. District Court in Wisconsin entered a preliminary injunction on July 25 prohibiting the Wisconsin Department of Health Services from continuing to enforce Wisconsin Medicaid's categorical ban on medically necessary gender confirming…
- July 25, 2018
Flack v. Wisconsin Department of Health Services Preliminary Injunction Decision
Read moreThe U.S. District Court for the Western District of Wisconsin issued a preliminary injunction prohibiting Wisconsin health officials from enforcing a sweeping ban on medically necessary care for Wisconsin's transgender Medicaid beneficiaries. Read the preliminary injunction decision in Flack v. Wisconsin Department of Health Services. Earlier this year, the…
- July 25, 2018
What’s Missing from Trump’s Plan for Lower Rx Costs?
Read moreThe Trump administration's recently issued "Blueprint to Lower Drug Prices and Reduce Out-of-Pocket Costs" fails to address the root cause of high cost prescription drugs: pharmaceutical company profiteering on backs of consumers and taxpayers. The Blueprint lists broad policy objectives the administration may pursue to lower drug costs –…